Your browser doesn't support javascript.
loading
Point-of-care high-sensitivity troponin-I analysis in capillary blood for acute coronary syndrome diagnostics.
Bruinen, Anne L; Frenk, Lisa D S; de Theije, Femke; Kemper, Daniëlle W M; Janssen, Marcel J W; Rahel, Braim M; Meeder, Joan G; van 't Hof, Arnoud W J.
Afiliação
  • Bruinen AL; VieCuri Medical Center, Venlo, The Netherlands.
  • Frenk LDS; VieCuri Medical Center, Venlo, The Netherlands.
  • de Theije F; Siemens Healthineers, Eindhoven, The Netherlands.
  • Kemper DWM; Siemens Healthineers, Eindhoven, The Netherlands.
  • Janssen MJW; VieCuri Medical Center, Venlo, The Netherlands.
  • Rahel BM; VieCuri Medical Center, Venlo, The Netherlands.
  • Meeder JG; VieCuri Medical Center, Venlo, The Netherlands.
  • van 't Hof AWJ; Maastricht University Medical Center, Maastricht, The Netherlands.
Clin Chem Lab Med ; 60(10): 1669-1674, 2022 09 27.
Article em En | MEDLINE | ID: mdl-35858956
OBJECTIVES: Patients with acute coronary syndrome (ACS) should be referred promptly to the hospital to reduce mortality and morbidity. Differentiating between low-risk and high-risk patients remains a diagnostic challenge. Point-of-care testing can contribute to earlier disposition decisions for patients excluded from ACS. This study describes the validation of the Atellica® VTLi. Patient-side Immunoassay Analyzer for high-sensitivity troponin point-of-care (POC) analysis. (The Atellica VTLi is not available for sale in the USA. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed). METHODS: A total of 152 patients with acute chest pain admitted at the cardiac emergency department (ED) were included in the study. Capillary blood was compared with a whole blood and plasma sample obtained by venipuncture. All samples were analyzed using the Atellica VTLi Patient-side Immunoassay Analyzer; in addition, plasma was analyzed by a central lab immunoassay analyzer. RESULTS: No significant difference was observed between venous whole blood vs. plasma analyzed by the Atellica VTLi Patient-side Immunoassay Analyzer. The difference between capillary blood and venous blood showed a constant bias of 7.1%, for which a correction factor has been implemented. No clinically relevant differences were observed for the capillary POC results compared to plasma analyzed with a standard immunoassay analyzer. CONCLUSIONS: The Atellica VTLi Patient-side Immunoassay Analyzer for high-sensitivity troponin analysis shows equivalent results for all sample types, including capillary blood. No clinically relevant discordances were observed between capillary POC and central laboratory results. With additional studies, this could pave the way towards rapid testing of high-sensitivity troponin in the ambulance or the general practitioner's office without the need for hospitalization of patients with acute chest pain.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troponina I / Síndrome Coronariana Aguda Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Chem Lab Med Assunto da revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troponina I / Síndrome Coronariana Aguda Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Chem Lab Med Assunto da revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda